↓ Cooling
Business
🔮 fades ✓
Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive
Tempus AI has entered into an agreement to acquire cancer test manufacturer Personalis for $1.5 billion, triggering a decline in both companies' share prices.